Risk Level: LowSubQ Inject
TB-500
Systemic Actin-Mediated Cell Migration & Anti-Fibrotic Tissue Repair
Aliases / Trademarks: Thymosin Beta-4 · LKKTETQ · Tβ4
The active 7-amino acid fragment of natural Thymosin Beta-4. Regulates cellular actin polymerization to drive endothelial cells and myoblasts rapidly to lesion sites while suppressing fibrotic scar adhesions.
Associated Protocol Category: View Protocol Roadmap
⏱️ Real-World Expectation & Sentiment Timeline
Week 1 - 2 (Loading Phase)：Acute Anti-Inflammatory & Cellular Migration Core Milestones
Deep muscle tightness and pulling pain decrease noticeably; overall joint mobility and fluidity expand
Stage Critical Guidance:Standard protocol uses 5mg weekly split into two 2.5mg injections (e.g. Monday and Thursday).
Standard Dosage & Administration Guidelines
Typical Dose
2.5mg - 5.0mg / week
Frequency
1 - 2 times weekly (e.g. 2.5mg Monday + 2.5mg Thursday)
Cycle Length
4 - 6 weeks per course
Clinical & Community Notes: Co-administering with BPC-157 (Wolverine Stack) is the undisputed gold standard for connective tissue and ligament recovery.
Titration Schedule & Dosing Decision Tree
Step-up ProtocolStarting & Maintenance Criteria:Loading Phase (Weeks 1-2): 5.0mg weekly (2.5mg Monday + 2.5mg Thursday)
Maintain for 4-6 weeks until injury pain is completely resolved
Titration & Adjustment Rules:Maintenance Phase: Shift to 2.0mg - 2.5mg once weekly
| Timeline | Dosage & Frequency | Objective | Key Biomarkers / Checks |
|---|---|---|---|
| Weeks 1 - 2 | 5.0mg weekly (split into two 2.5mg doses) | Rapid actin mobilization and acute anti-inflammatory action | Muscle knot softening, joint mobility |
Educational Composite Scenarios
1 Composite Archetypesℹ️ Names, timelines, doses, lab values, and outcomes are illustrative composites. They are not actual patient records or treatment recommendations.
6-Week Wolverine Stack: Grade 2 Supraspinatus Partial Tear Full Recovery
👤 Composite Profile: Male, 36yo, badminton player, chronic right shoulder impingement & partial supraspinatus tear for 8 months.
Illustrative Protocol: BPC-157 (250mcg SubQ BID) + TB-500 (2.5mg SubQ 2x/wk) for 6 weeks, paired with light isometric rotator cuff rehab from Week 3.
Illustrative Timeline:
Week 1Abduction 80° -> 110°
Nighttime sleep compression pain vanished by Day 4 with no morning burning sensation.
Week 3Abduction 110° -> 165°
Dressing and overhead reach became pain-free; initiated isometric band rotations.
Week 6Full 180° Abduction Range
Follow-up ultrasound confirmed restored hyperechoic collagen continuity and zero fluid effusion.
Scenario Outcome and Learning Points: 3-month post-cycle follow-up showed zero recurrence. Full return to overhead sports without surgical intervention.
💡 Educational Takeaway: Systemic abdominal SubQ is pharmacokinetically identical to local joint shots with zero risk of capsular infection; do not overload prematurely.
Visual Syringe Reconstitution Calculator
Accurately calculate vial reconstitution concentration and U-100 syringe units
Syringe:
Quick Clinical & Community Presets:
mg
ml
mcg
Syringe Pull To Mark
100Units (Ticks on Syringe)
Equal to 1.000 ml fluid | Yields 2 doses
Conc: 2.50 mg/ml
💉 Visual Needle Simulation (U-100 Standard)Target: 100 / 100 U
① Dissolution Technique: Slowly slide BAC water down the vial wall. Never shake vigorously to protect peptide chains.
② Cold-Chain Storage: Store reconstituted liquid at 2-8°C away from light. Best used within 28-30 days.
③ Standard Syringe: Calculation based on U-100 insulin syringes (100 units = 1.0 ml).
Evidence-Based FAQs & Reddit Theoretical Mythbusters
Verified biochemical mechanisms, category physiology, and Reddit misconception clarity
1. Compound-Specific Dilemmas & Solutions
🔗 Synergistic Stacking Protocols (Synergies)
Synergy Stack
+ BPC-157
Forms the golden Wolverine Stack for comprehensive connective tissue repair.
📊 Educational Composite Scenarios (1)
Illustrative 6-16 week timelines, sample biomarker metrics, and educational protocol takeaways for TB-500.
ℹ️ Names, timelines, doses, lab values, and outcomes are illustrative composites. They are not actual patient records or treatment recommendations.
Textbook ResponderMale, 36 y/o•6 Weeks Protocol
6-Week Wolverine Stack: Grade 2 Supraspinatus Partial Tear Full Recovery
Illustrative Protocol: BPC-157 (250mcg SubQ BID) + TB-500 (2.5mg SubQ 2x/wk) for 6 weeks, paired with light isometric rotator cuff rehab from Week 3.
Abduction ROM
180°
+100° (Full 180° Painless)
VAS Pain Score
0.5 / 10
-93.3% (Pain Free)
Ultrasound Continuity
Reported change
Edema Completely Cleared
Illustrative Weekly Highlights:
Week 1Nighttime sleep compression pain vanished by Day 4 with no morning burning sensation.
Week 3Dressing and overhead reach became pain-free; initiated isometric band rotations.
Week 6Follow-up ultrasound confirmed restored hyperechoic collagen continuity and zero fluid effusion.
💡 Educational Takeaway: Systemic abdominal SubQ is pharmacokinetically identical to local joint shots with zero risk of capsular infection; do not overload prematurely.
Inspect Full Scenario Dossier →Dedicated Dose & Syringe Calculator
💉 TB-500 Reconstitution & Syringe Tick Tool
Standard vial size: 5mg. Recommended BAC water: 2ml. Typical dose: 2.5mg - 5.0mg / week.
Visual Syringe Reconstitution Calculator
Accurately calculate vial reconstitution concentration and U-100 syringe units
Syringe:
Quick Clinical & Community Presets:
mg
ml
mcg
Syringe Pull To Mark
10Units (Ticks on Syringe)
Equal to 0.100 ml fluid | Yields 20 doses
Conc: 2.50 mg/ml
💉 Visual Needle Simulation (U-100 Standard)Target: 10 / 100 U
① Dissolution Technique: Slowly slide BAC water down the vial wall. Never shake vigorously to protect peptide chains.
② Cold-Chain Storage: Store reconstituted liquid at 2-8°C away from light. Best used within 28-30 days.
③ Standard Syringe: Calculation based on U-100 insulin syringes (100 units = 1.0 ml).
Evidence Context and Common Questions
TB-500 Key TakeawaysResearch References
References may include preclinical or clinical research and do not establish safety, efficacy, or dosing for an individual.
Thymosin beta4 accelerates wound healing in clinical trials
Annals of the New York Academy of Sciences · 2010